Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration

NCT00805233 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT00805233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00805233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration
Lead sponsor
Oregon Health and Science University
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
September 30, 2010
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration